Loading organizations...
Loading organizations...
Key people at Bayland Capital.
Key people at Bayland Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 16, 2025 | BridGene Biosciences | $28.0M Series B | Yuexing Su | Grains Valley Venture Capital, GTJA Investment Group, Lapam Capital, Proxima Ventures |
| May 7, 2025 | PAQ Therapeutics | $39.0M Series B | Yuexing Su, Olga Danilchanka | Johnson & Johnson Innovation, Lilly Asia Ventures, Sherpa Healthcare Partners |
| Apr 23, 2024 | CN Bio | $21.0M Series B | Yuexing Su | — |
| Nov 11, 2022 | PureID Medical Technology | $14.0M Series B | Legend Capital | — |
| Nov 10, 2022 | Pure Global | $13.8M Series B | Legend Capital | — |
| Nov 18, 2020 | Wuxi Biortus Biosciences | $15.0M Series A | Bayland Capital | — |